Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group.

Kiviniemi MT, Hay JL, James AS, Lipkus IM, Meissner HI, Stefanek M, Studts JL, Bridges JF, Close DR, Erwin DO, Jones RM, Kaiser K, Kash KM, Kelly KM, Craddock Lee SJ, Purnell JQ, Siminoff LA, Vadaparampil ST, Wang C.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3133-7. doi: 10.1158/1055-9965.EPI-18-11-ASPO. Review. No abstract available.

2.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T.

N Engl J Med. 2004 Jun 17;350(25):2572-81.

4.

Matrix metalloproteinase inhibitors in rheumatic diseases.

Close DR.

Ann Rheum Dis. 2001 Nov;60 Suppl 3:iii62-7. Review.

5.

Associations of demographic and health-related characteristics with prostate cancer screening in Washington State.

Close DR, Kristal AR, Li S, Patterson RE, White E.

Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):627-30.

6.

Phase II trial of piroxantrone in metastatic gastric adenocarcinoma.

Pazdur R, Bready B, Scalzo AJ, Brandof JE, Close DR, Kolbye S, Winn RJ.

Invest New Drugs. 1994;12(3):263-5.

PMID:
7896547

Supplemental Content

Loading ...
Support Center